发明名称 FUSED RING 4-OXOPYRIMIDINE DERIVATIVE
摘要 A compound represented by the formula (I): (I) [wherein Ar represents a divalent group formed by removing two hydrogen atoms from benzene, etc.; Xrepresents nitrogen, sulfur, or oxygen; Rrepresents 5- or 6-membered heteroaryl, etc.; ring A represents 5- or 6-membered heteroaryl ring, etc.; Rand Reach represents amino, alkylamino, etc.; and -Xrepresents, e.g., a group represented by the formula (II): (II) (wherein Rand Reach represents lower alkyl, etc.; and n is an integer of 2 to 4)] or a pharmaceutically acceptable salt of the compound. The compound or salt has antagonistic activity against a histamine H3 receptor or inverse agonistic activity against a histamine H3 receptor and is useful in the prevention or treatment of metabolic diseases, circulatory diseases, or neurotic diseases.(1),(II)
申请公布号 UA83416(C2) 申请公布日期 2008.07.10
申请号 UA20060009795 申请日期 2005.02.14
申请人 BANYU PHARMACEUTICAL CO., LTD. 发明人 NAGASE TSUYOSHI;SATO NAGAAKI;KANATASI AKIO;TOKITA SHIGERU
分类号 C07D217/24;A61K31/4725;A61K31/517;A61K31/519;A61K31/55;A61K45/06;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P3/12;A61P5/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P13/12;A61P19/06;A61P25/02;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P43/00;C07D239/70;C07D239/91;C07D401/04;C07D401/12;C07D403/04;C07D403/12;C07D471/04;C07D487/08 主分类号 C07D217/24
代理机构 代理人
主权项
地址